Tiger Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tiger Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-793,933	Closed	-$12.8M	–	65
2016 Q4	$12.8M	Buy	793,933 +120,000	+18%	+$2.18M	2.33%	18
2016 Q3	$12.2M	Sell	673,933 -220,644	-25%	-$4.31M	2.89%	13
2016 Q2	$14.7M	Buy	894,577 +26,100	+3%	+$422K	4.75%	12
2016 Q1	$14.4M	Buy	868,477 +44,900	+5%	+$786K	3.61%	14
2015 Q4	$17.8M	Buy	+823,577	New	+$16M	2.3%	19

Other funds holding HZNP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Tiger Management's HZNP Position: Q1 2017 in Review

Tiger Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2017, closing a stake of 793,933 shares — an estimated $12.8M sold.

Tiger Management first reported a position in HZNP in Q4 2015 and held it in 5 quarters. The position peaked at $17.8M in Q4 2015. 210 funds tracked by Wall St. Rank hold HZNP as of Q1 2017.

Tiger Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2017 after selling out during the quarter.
Tiger Management sold 793,933 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2017, an estimated $12.8M.
Tiger Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 5 quarters.
Tiger Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $17.8M in Q4 2015.
210 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2017.

Based on Tiger Management's 13F filing for Q1 2017, filed 15 May 2017.